1Ferre N. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage[Jl. Clin Chem, 2002, 48:261-268.
2National Committee for Clinical Laboratory Standards.Precision performance of cli-nical chemistry devices[ S].edition. Tentative guideline, NCCLS, EP5-T2, 1992.
3National Committee for Clinical Laboratory Standards.Precision performance of cli-nical chemistry devices[ S].edition. Tentative guideline, NCCLS, EP6, 1991.
4Banka CL. High density lipoprotein and lipoprotein oxidation[J ]. Curr Opin Lipidol, 1996, 7 : 139-142.
5Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein[J ]. FEBS Lett, 1991, 286 : 152-154.
6Dharambir K,Saha N,Kamboh I.The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese[].Atherosclerosis.1998
7Mcelveen J,Mackness M,Colley M.Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction[].Clinical Chemistry.1986
8Mackness M,Durrington P,Boulton.Serum paraoxonase activity in familial hypercholesterolaemic and insulin-dependent diabetes mellitus[].Atherosclerosis.1991
9LaDu,Mach K.Studies on human serum paraoxonase/arylerase[].Chemico Biological Interactions.1993
10Mickenss B,Mackness M,Arrol S.Serum paraoxonase 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetets mellitus[].Chemico Biological Interactions.1993
6Aslan M,Horoz M,Nazligul Y,et al.Serum paraoxonase andarylesterase activities for the evaluation of patients with chronichepatitis[J].Int J Clin Pract,2008,62(7):1050-1055.
7Kedage V,Muttigi MS,Shetty MS,et al.Serum paraoxonase 1ac-tivity status in patients with liver disorders[J].Saudi J Gastroen-terol,2010,16(2):79-83.
8Marsillach J,Camps J,FerréN,et al.Paraoxonase-1is related toinflammation,fibrosis and PPAR delta in experimental liver dis-ease[J].BMC Gastroenterol,2009,9(2):3-9.
